Milan: (RightNow) A new drug, CBL-514, has proven effective in reducing weight. This fat-dissolving medication could play a significant role in combating obesity.

American experts suggest that this drug could be an alternative to cosmetic procedures like liposuction. It also reduces visceral fat that accumulates around internal organs.

According to experts from the University of Alabama, CBL-514 reduced subcutaneous fat in 70% of patients. It can prevent weight gain when used after Mounjaro or Wegovy.

Research indicates that the combined use of CBL-514 and tirzepatide enhances weight loss effects. These findings were presented at the European Association for the Study of Diabetes meeting.

It is noteworthy that, according to Dr. Timothy Garvey, besides visible benefits, reducing internal fat and improving blood pressure are crucial for health.